The Atlanta Braves' designated hitter Jurickson Profar is facing a 162-game suspension after testing positive for a performance-enhancing drug for the second time in the last year. This is a significant blow to the team, who have already lost key players to injuries and are trying to rebound from a challenging season. Profar's suspension comes after he was signed to a three-year, $42 million contract last January, and his absence will put more pressure on other players to produce. Profar's positive test result is a stark reminder of the ongoing issue of performance-enhancing drugs in baseball, and it raises questions about the effectiveness of the league's penalties for repeat offenders. The Braves' management and fans are left to wonder if this suspension will be enough to deter future violations and protect the integrity of the sport.
